Stay updated on Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Arms B and C are closed to enrollment, and Arm A remains open for enrollment.
    Difference
    0.4%
    Check dated 2025-11-03T21:21:41.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T05:58:42.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to core content or functionality based on the provided additions/deletions.
    Difference
    0.1%
    Check dated 2025-09-29T03:15:20.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Version bumped to v3.0.2; previous revision v3.0.1 removed and Back to Top element deleted.
    Difference
    0.2%
    Check dated 2025-09-14T21:40:55.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T17:45:37.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as specific drug names like pembrolizumab and 130-nm albumin-bound paclitaxel, while removing various terms related to lung cancer and antineoplastic agents.
    Difference
    3%
    Check dated 2025-08-31T12:18:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.